Plastin-3 extends survival and reduces severity in mouse models of spinal muscular atrophy
Page 1 of 1
Plastin-3 extends survival and reduces severity in mouse models of spinal muscular atrophy
Jon Moulton Thu Mar 16, 2017 12:40 pm
Kaifer KA, Villalón E, Osman EY, Glascock JJ, Arnold LL, Cornelison DD, Lorson CL. Plastin-3 extends survival and reduces severity in mouse models of spinal muscular atrophy. JCI Insight. 2017 Mar 9;2(5):e89970. doi: 10.1172/jci.insight.89970.
Last edited by Jon Moulton on Thu Mar 16, 2017 12:41 pm; edited 1 time in total (Reason for editing : Fix URL)
Jon Moulton- Posts : 5721
Join date : 2010-03-12
Age : 62
Location : Philomath, Oregon, USA -
Similar topics» Plastin 3 Expression Does Not Modify Spinal Muscular Atrophy Severity in the ∆7 SMA Mouse
» Identification of a Peptide for Systemic Brain Delivery of a Morpholino Oligonucleotide in Mouse Models of Spinal Muscular Atrophy
» A single administration of morpholino antisense oligomer rescues spinal muscular atrophy in the mouse
» Investigation of New Morpholino Oligomers to Increase Survival Motor Neuron Protein Levels in Spinal Muscular Atrophy
» Systemic peptide-mediated oligonucleotide therapy improves long-term survival in spinal muscular atrophy
» Identification of a Peptide for Systemic Brain Delivery of a Morpholino Oligonucleotide in Mouse Models of Spinal Muscular Atrophy
» A single administration of morpholino antisense oligomer rescues spinal muscular atrophy in the mouse
» Investigation of New Morpholino Oligomers to Increase Survival Motor Neuron Protein Levels in Spinal Muscular Atrophy
» Systemic peptide-mediated oligonucleotide therapy improves long-term survival in spinal muscular atrophy
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum